Anti-Sp100 ANA are present in around 30–50% of AMA-negative PBC patients [2,22] although they could be also detected in some other conditions (systemic autoimmune diseases and hepatotropic virus infections) [60]. Here, SP100 is linked to primary biliary cholangitis.